Related Experiment Video
Updated: Mar 6, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
Personalized Medicine: Pharmacogenomics and Drug Development
Somayeh Mirsadeghi1, Bagher Larijani2
1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Acta Medica Iranica
|March 12, 2017
Summary
Pharmacogenomics (PGx) uses genetic information to tailor drug treatments, ensuring the right medication and dosage for each patient. This approach enhances treatment success and minimizes adverse drug reactions for personalized medicine.
Area of Science:
- Pharmacogenomics
- Personalized Medicine
- Drug Discovery
Background:
- Personalized medicine aims to optimize drug therapy for individual patients.
- Pharmacogenomics (PGx) identifies genetic variations impacting drug response.
- Understanding genetic influences on pharmacokinetics and pharmacodynamics is crucial.
Purpose of the Study:
- To predict individual patient responses to specific drugs.
- To enhance therapeutic success rates.
- To reduce the occurrence of adverse drug reactions.
Main Methods:
- Genetic variant analysis.
- Drug efficacy and toxicity assessment.
- Clinical patient data integration.
Main Results:
- Identification of genetic markers influencing drug response.
- Improved prediction of treatment outcomes.
- Reduced incidence of adverse drug events.
Conclusions:
- Pharmacogenomics enables precise drug selection and dosing.
- Predictive genetic assessment is key to effective personalized medicine.
- Tailoring treatments based on genetics improves patient safety and therapy effectiveness.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
01:29Pharmacogenetics and Pharmacogenomics: Overview
98
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
98
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
76
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
76
01:27Pharmacogenetics of Drug Metabolism: Overview
74
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
74
01:27Principles of Pharmacogenetics: Types of Genetic Variants
65
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
65
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56